Laupacis A. Evidence and Values: Requirements for Public Reimbursement of Drugs for Rare Diseases- A Case Study in Oncology- Reply. J Popl Ther Clin Pharmacol. 2018;16(2). Accessed November 19, 2024. https://mail.jptcp.com/index.php/jptcp/article/view/557